• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis.

作者信息

Lippi Giuseppe, Sanchis-Gomar Fabian, Henry Brandon M

机构信息

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.

出版信息

Clin Chem Lab Med. 2021 Sep 2;60(1):e1-e3. doi: 10.1515/cclm-2021-0848. Print 2022 Jan 26.

DOI:10.1515/cclm-2021-0848
PMID:34472764
Abstract
摘要

相似文献

1
Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis.前降钙素原值可预测发生重症/危重症新型冠状病毒肺炎的风险：一项汇总分析结果
Clin Chem Lab Med. 2021 Sep 2;60(1):e1-e3. doi: 10.1515/cclm-2021-0848. Print 2022 Jan 26.
2
Presepsin as a predictive biomarker of severity in COVID-19: A case series.前降钙素作为新型冠状病毒肺炎严重程度的预测生物标志物：病例系列
J Med Virol. 2021 Jan;93(1):99-101. doi: 10.1002/jmv.26164. Epub 2020 Jun 24.
3
Clinical Value of Presepsin in Comparison to hsCRP as a Monitoring and Early Prognostic Marker for Sepsis in Critically Ill Patients.与超敏C反应蛋白相比，前降钙素原作为重症患者脓毒症监测及早期预后标志物的临床价值
Medicina (Kaunas). 2019 Feb 2;55(2):36. doi: 10.3390/medicina55020036.
4
Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients.降钙素原和可溶性髓系细胞触发受体-1在危重症患者中预测SeptiFast检测结果的应用。
J Crit Care. 2017 Aug;40:197-201. doi: 10.1016/j.jcrc.2017.04.008. Epub 2017 Apr 8.
5
Presepsin as a prognostic biomarker in COVID-19 patients: combining clinical scoring systems and laboratory inflammatory markers for outcome prediction.可溶性髓系细胞触发受体-1作为COVID-19患者的预后生物标志物：结合临床评分系统和实验室炎症标志物进行预后预测。
Virol J. 2024 Apr 26;21(1):96. doi: 10.1186/s12985-024-02367-1.
6
Usefulness of presepsin for early detection of infections in patients with hematologic disorders.前降钙素原在血液系统疾病患者感染早期检测中的应用价值。
Clin Chim Acta. 2018 Nov;486:374-380. doi: 10.1016/j.cca.2018.08.032. Epub 2018 Aug 23.
7
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.可溶性CD14亚型（前降钙素）在重症监护治疗第一周对严重脓毒症和脓毒性休克的诊断及预后评估价值
Crit Care. 2014 Sep 5;18(5):507. doi: 10.1186/s13054-014-0507-z.
8
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis.血清淀粉样蛋白前体作为儿童和青少年脓毒症的诊断标志物：系统评价和荟萃分析。
BMC Infect Dis. 2019 Aug 30;19(1):760. doi: 10.1186/s12879-019-4397-1.
9
Diagnostic Value of Presepsin in Detection of Early-Onset Neonatal Sepsis.前降钙素原在早发型新生儿败血症检测中的诊断价值
Am J Perinatol. 2017 May;34(6):550-556. doi: 10.1055/s-0036-1593851. Epub 2016 Nov 8.
10
Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.降钙素原、可溶性髓系细胞触发受体-1和C反应蛋白在血液系统恶性肿瘤患者中的诊断效能
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22147. Epub 2017 Jan 30.

引用本文的文献

1
The Evaluation of New-Generation Biomarker sCD14ST Provides New Insight into COVID-19's Effect on Bone Remodeling.新一代生物标志物可溶性CD14亚型（sCD14ST）的评估为新冠病毒病（COVID-19）对骨重塑的影响提供了新见解。
J Clin Med. 2025 Feb 3;14(3):979. doi: 10.3390/jcm14030979.
2
Presepsin in Critical Illness: Current Knowledge and Future Perspectives.危重症中的前降钙素：当前认知与未来展望。
Diagnostics (Basel). 2024 Jun 20;14(12):1311. doi: 10.3390/diagnostics14121311.
3
Novel inflammatory biomarkers in the prognosis of COVID-19.新型炎症生物标志物在 COVID-19 预后中的作用。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231199679. doi: 10.1177/17534666231199679.
4
Utility of Presepsin and Interferon-λ3 for Predicting Disease Severity and Clinical Outcomes in COVID-19 Patients.降钙素原和干扰素-λ3在预测COVID-19患者疾病严重程度和临床结局中的应用
Diagnostics (Basel). 2023 Jul 14;13(14):2372. doi: 10.3390/diagnostics13142372.
5
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19).血小板计数和降钙素原浓度的联合日测可预测重症 2019 冠状病毒病（COVID-19）患者的住院死亡。
Int J Hematol. 2023 Jun;117(6):845-855. doi: 10.1007/s12185-023-03555-5. Epub 2023 Mar 15.
6
Presepsin levels and COVID-19 severity: a systematic review and meta-analysis.血清淀粉样蛋白 A 与 COVID-19 严重程度的关系：系统评价和荟萃分析。
Clin Exp Med. 2023 Aug;23(4):993-1002. doi: 10.1007/s10238-022-00936-8. Epub 2022 Nov 15.
7
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.心脏生物酶在预测2019冠状病毒病心血管结局中的作用
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
8
Presepsin Predicts Severity and Secondary Bacterial Infection in COVID-19 by Bioinformatics Analysis.基于生物信息学分析的可溶性 CD14 亚型预测 COVID-19 严重程度和继发细菌感染
Comput Math Methods Med. 2022 Sep 6;2022:9914927. doi: 10.1155/2022/9914927. eCollection 2022.